Literature DB >> 12761137

CD40 contributes to lethality in acute sepsis: in vivo role for CD40 in innate immunity.

Jeffrey A Gold1, Merdad Parsey, Yoshihiko Hoshino, Satomi Hoshino, Anna Nolan, Herman Yee, Doris B Tse, Michael D Weiden.   

Abstract

Sepsis induces an early inflammatory cascade initiated by the innate immune response. This often results in the development of multisystem organ failure. We examined the role of CD40, a costimulatory molecule that is integral in adaptive immunity, by using a murine model of polymicrobial sepsis. CD40 knockout (KO) mice had delayed death and improved survival after cecal ligation and puncture (CLP). In addition, they had less remote organ injury as manifested by reduced pulmonary capillary leakage. The improvements in survival and remote organ dysfunction in CD40 KO mice were associated with reduced interleukin-6 (IL-6) and IL-10 levels in serum and bronchoalveolar lavage fluid compared to the levels in wild-type (WT) controls. Furthermore, in contrast to WT mice, CD40 KO mice had no induction of the Th1 cytokines IL-12 and gamma interferon in serum or lungs after CLP. The alterations in cytokine production in CD40 KO mice were associated with similar changes in transcription factor activity. After CLP, CD40 KO mice had attenuated activation of nuclear factor kappaB and signal transducer and activator of transcription 3 in both the lung and the liver. Finally, WT mice had increased expression of CD40 on their alveolar macrophages. These data highlight the importance of CD40 activation in the innate immune response during polymicrobial sepsis and the subsequent development of remote organ dysfunction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761137      PMCID: PMC155725          DOI: 10.1128/IAI.71.6.3521-3528.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Multiple roles for IL-12 in a model of acute septic peritonitis.

Authors:  M L Steinhauser; C M Hogaboam; N W Lukacs; R M Strieter; S L Kunkel
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

Review 2.  Sepsis and evolution of the innate immune response.

Authors:  B Beutler; A Poltorak
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

3.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

4.  Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism.

Authors:  K Adachi; H Tsutsui; S Kashiwamura; E Seki; H Nakano; O Takeuchi; K Takeda; K Okumura; L Van Kaer; H Okamura; S Akira; K Nakanishi
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

5.  CD40 ligation prevents Trypanosoma cruzi infection through interleukin-12 upregulation.

Authors:  D Chaussabel; F Jacobs; J de Jonge; M de Veerman; Y Carlier; K Thielemans; M Goldman; B Vray
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  Role of CD40-CVD40L in mouse severe malaria.

Authors:  P F Piguet; C D Kan; C Vesin; A Rochat; Y Donati; C Barazzone
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

7.  Early activation of hepatic NFkappaB and NF-IL6 in polymicrobial sepsis correlates with bacteremia, cytokine expression, and mortality.

Authors:  D L Williams; T Ha; C Li; J H Kalbfleisch; D A Ferguson
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

8.  Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.

Authors:  K Takeda; B E Clausen; T Kaisho; T Tsujimura; N Terada; I Förster; S Akira
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

9.  Intrahepatic STAT-3 activation and acute phase gene expression predict outcome after CLP sepsis in the rat.

Authors:  K M Andrejko; J Chen; C S Deutschman
Journal:  Am J Physiol       Date:  1998-12

10.  Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis.

Authors:  A Matsukawa; M H Kaplan; C M Hogaboam; N W Lukacs; S L Kunkel
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  25 in total

1.  Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.

Authors:  Birgit Liliensiek; Markus A Weigand; Angelika Bierhaus; Werner Nicklas; Michael Kasper; Stefan Hofer; Jens Plachky; Herman-Josef Gröne; Florian C Kurschus; Ann Marie Schmidt; Shi Du Yan; Eike Martin; Erwin Schleicher; David M Stern; G ünterJ Hämmerling G; Peter P Nawroth; Bernd Arnold
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

Review 2.  Understanding RAGE, the receptor for advanced glycation end products.

Authors:  Angelika Bierhaus; Per M Humpert; Michael Morcos; Thoralf Wendt; Triantafyllos Chavakis; Bernd Arnold; David M Stern; Peter P Nawroth
Journal:  J Mol Med (Berl)       Date:  2005-08-24       Impact factor: 4.599

3.  Vascular endothelial growth factor blockade reduces plasma cytokines in a murine model of polymicrobial sepsis.

Authors:  Anna Nolan; Michael D Weiden; Gavin Thurston; Jeffrey A Gold
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

4.  CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis.

Authors:  Anna Nolan; Michael Weiden; Ann Kelly; Yoshihiko Hoshino; Satomi Hoshino; Nehal Mehta; Jeffrey A Gold
Journal:  Am J Respir Crit Care Med       Date:  2007-11-07       Impact factor: 21.405

5.  Cecal ligation and puncture-induced murine sepsis does not cause lung injury.

Authors:  Kendra N Iskander; Florin L Craciun; David M Stepien; Elizabeth R Duffy; Jiyoun Kim; Rituparna Moitra; Louis J Vaickus; Marcin F Osuchowski; Daniel G Remick
Journal:  Crit Care Med       Date:  2013-01       Impact factor: 7.598

6.  Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Jason R Mock; Yoshiki Eto; Brian T Garibaldi; Daniel C Files; Claudia R Avalos; Jackie V Rodriguez; Adam T Waickman; Sekhar P Reddy; David B Pearse; Venkataramana K Sidhaye; Paul M Hassoun; Michael T Crow; Landon S King
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

7.  Mouse eosinophils possess potent antibacterial properties in vivo.

Authors:  Stefanie N Linch; Ann M Kelly; Erin T Danielson; Ralph Pero; James J Lee; Jeffrey A Gold
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

8.  Regulatory roles of CD1d-restricted NKT cells in the induction of toxic shock-like syndrome in an animal model of fatal ehrlichiosis.

Authors:  H L Stevenson; E C Crossley; N Thirumalapura; D H Walker; N Ismail
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

9.  Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis.

Authors:  Anna Nolan; Hiroshi Kobayashi; Bushra Naveed; Ann Kelly; Yoshihiko Hoshino; Satomi Hoshino; Matthew R Karulf; William N Rom; Michael D Weiden; Jeffrey A Gold
Journal:  PLoS One       Date:  2009-08-12       Impact factor: 3.240

10.  Protective effect of resin adsorption on septic plasma-induced tubular injury.

Authors:  Vincenzo Cantaluppi; Viktoria Weber; Carola Lauritano; Federico Figliolini; Silvia Beltramo; Luigi Biancone; Massimo De Cal; Dinna Cruz; Claudio Ronco; Giuseppe Paolo Segoloni; Ciro Tetta; Giovanni Camussi
Journal:  Crit Care       Date:  2010-01-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.